Published in BMJ on November 19, 1994
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ (2008) 3.62
Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One (2008) 3.05
Who goes to sexually transmitted disease clinics? Results from a national population survey. Genitourin Med (1996) 3.02
Informal confidential voting interview methods and temporal changes in reported sexual risk behaviour for HIV transmission in sub-Saharan Africa. Sex Transm Infect (2004) 2.99
The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect (2000) 2.25
The role of epidemiology and surveillance systems in the control of sexually transmitted diseases. Genitourin Med (1996) 2.16
Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA (2011) 1.85
Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK. Sex Transm Infect (2003) 1.70
Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group. Genitourin Med (1997) 1.66
Comparison of risk factors for four sexually transmitted infections: results from a study of attenders at three genitourinary medicine clinics in England. Sex Transm Infect (2000) 1.64
A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect (2005) 1.54
The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect (2004) 1.49
Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes. Sex Transm Infect (1998) 1.40
The sexual health of pupils in years 4 to 6 of primary schools in rural Tanzania. Sex Transm Infect (2004) 1.27
Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect (2003) 1.27
Patient attitudes to type specific serological tests in the diagnosis of genital herpes. Genitourin Med (1997) 1.27
Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm Infect (2006) 1.26
Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect (1999) 1.24
HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa. Epidemics (2010) 1.22
Behavioural data as an adjunct to HIV surveillance data. Sex Transm Infect (2006) 1.20
Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study. BMC Infect Dis (2004) 1.19
Prevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California. West J Med (2000) 1.16
Risk behaviors of 15-21 year olds in Mexico lead to a high prevalence of sexually transmitted infections: results of a survey in disadvantaged urban areas. BMC Public Health (2006) 1.13
Improving the care of patients with genital herpes. BMJ (2000) 1.11
Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transm Infect (2002) 1.07
British Co-operative Clinical Group national survey on diagnostic issues surrounding genital herpes. MSSVD Special Interest Group on Genital Herpes and the British Co-operative Clinical Group. Sex Transm Infect (1999) 1.04
Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex Transm Infect (2004) 1.03
Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sex Transm Infect (2002) 1.03
Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic. Sex Transm Infect (2001) 0.98
Neonatal herpes prevention: a minor public health problem in some communities. Sex Transm Infect (2000) 0.98
Body mass index, sexual behaviour, and sexually transmitted infections: an analysis using the NHANES 1999-2000 data. BMC Public Health (2006) 0.91
Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage. Sex Transm Infect (1998) 0.91
The acceptability of the introduction of a type specific herpes antibody screening test into a genitourinary medicine clinic in the United Kingdom. Sex Transm Infect (2003) 0.91
Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders. Sex Transm Infect (2001) 0.88
Herpes simplex type 2 infection in a cohort aged 21 years. Sex Transm Infect (1998) 0.88
Risk factors of herpes simplex type 1 (HSV-1) infection and lifestyle factors associated with HSV-1 manifestations. Eur J Epidemiol (2001) 0.86
Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect (2001) 0.86
Should Men who have sex with Men be allowed to donate blood in Israel? Isr J Health Policy Res (2016) 0.85
HSV type specific serology in sexual health clinics: use, benefits, and who gets tested. Sex Transm Infect (2004) 0.84
Semen donors and STD screening. Genitourin Med (1997) 0.84
Comparison of a monoclonal antibody-blocking enzyme-linked immunoassay and a strip immunoblot assay for identifying type-specific herpes simplex virus type 2 serological responses. Clin Diagn Lab Immunol (2000) 0.83
Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and HIV over time (1984-2003). Eur J Epidemiol (2007) 0.83
Genital herpes, "the new paradigm". J Clin Pathol (1999) 0.81
How safe is safer sex? High levels of HSV-1 and HSV-2 in female sex workers in London. Epidemiol Infect (2006) 0.81
A comparison of referral patterns and characteristics of patients with first episode symptomatic genital HSV-1 and HSV-2 infections in Sheffield. Genitourin Med (1996) 0.80
Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries. PLoS One (2015) 0.79
Herpes simplex virus infections among rural residents in eastern China. BMC Infect Dis (2011) 0.79
Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007. Trop Med Int Health (2013) 0.78
An evidence based approach to testing for antibody to herpes simplex virus type 2. Sex Transm Infect (2002) 0.78
Genital herpes. BMJ Clin Evid (2011) 0.76
Who Is Going for VCT? A Case Study in Urban Burkina Faso. ISRN AIDS (2012) 0.75
Prostate-specific antigen, sexual behavior, and sexually transmitted infections in US men 40-59 years old, 2001-2004: a cross-sectional study. Infect Agent Cancer (2007) 0.75
Seropositivity and risk factors for herpes simplex virus type 2 infection among female sex workers in Guangxi, China. PLoS One (2013) 0.75
Genital herpes: oral antiviral treatments. BMJ Clin Evid (2015) 0.75
Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging Studies. J Am Geriatr Soc (2016) 0.75
Genital herpes. BMJ Clin Evid (2007) 0.75
Clinical Evidence: Genital herpes. West J Med (1999) 0.75
Herpes simplex virus infection in women: viral subtypes and epidemiological features in a district hospital. Genitourin Med (1996) 0.75
Serum HSV-1 and 2 IgM in Sexually Transmitted Diseases - More for Screening Less for Diagnosis: An Evaluation of Clinical Manifestation. J Glob Infect Dis (2012) 0.75
Sexual lifestyles and HIV risk. Nature (1992) 8.24
Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol (1988) 8.09
Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl (1990) 4.02
Risk factors for the sexual transmission of genital herpes. Ann Intern Med (1992) 3.89
A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med (1989) 2.94
Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis (1985) 2.64
Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br J Vener Dis (1982) 2.48
Sexually transmitted diseases in children: adolescents. Genitourin Med (1993) 2.27
Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann Intern Med (1991) 2.12
The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis (1990) 2.00
Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88. Genitourin Med (1990) 1.96
Prevalence and correlates of herpes simplex infections. The population-based AIDS in Multiethnic Neighborhoods Study. JAMA (1992) 1.71
A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis (1990) 1.70
Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis (1990) 1.67
Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis (1988) 1.44
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08
Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet (2001) 9.75
Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol (1988) 8.09
Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med (1983) 7.89
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71
Sexual behaviour in Britain: early heterosexual experience. Lancet (2001) 7.62
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Mucosal shedding of human herpesvirus 8 in men. N Engl J Med (2000) 6.59
Measuring sexual behaviour: methodological challenges in survey research. Sex Transm Infect (2001) 6.21
Clinical and epidemiologic features of primary HIV infection. Ann Intern Med (1996) 6.04
Chloroplast transformation in Chlamydomonas with high velocity microprojectiles. Science (1988) 5.91
Plasma viremia in human immunodeficiency virus infection. N Engl J Med (1989) 5.73
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med (1997) 5.72
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A (1998) 5.48
Biological and virologic characteristics of primary HIV infection. Ann Intern Med (1998) 5.45
Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet (1991) 5.42
Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ (1997) 5.29
Chronic fatigue in adolescents. Pediatrics (1991) 5.24
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
Sexually transmitted infections and risk behaviours in women who have sex with women. Sex Transm Infect (2000) 4.89
Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat Med (1999) 4.81
Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA (2001) 4.54
Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ (2000) 4.51
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med (1996) 4.43
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med (2000) 4.39
Human C'3: evidence for the liver as the primary site of synthesis. Science (1969) 4.17
The 2010 Royal Australasian College of Physicians' policy statement 'Circumcision of infant males' is not evidence based. Intern Med J (2012) 4.15
Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol (1981) 4.10
From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. BMJ (1998) 4.09
Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med (1995) 4.03
Risk factors for the sexual transmission of genital herpes. Ann Intern Med (1992) 3.89
T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med (1996) 3.88
Pupil-led sex education in England (RIPPLE study): cluster-randomised intervention trial. Lancet (2004) 3.86
Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med (1994) 3.83
The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA (1988) 3.73
The acquisition of herpes simplex virus during pregnancy. N Engl J Med (1997) 3.73
A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med (1982) 3.66
Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56
Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest (1997) 3.52
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol (1999) 3.48
Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med (1987) 3.42
Modeling plasma virus concentration during primary HIV infection. J Theor Biol (2000) 3.40
Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med (1996) 3.35
Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med (1980) 3.33
Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med (1981) 3.32
Controlling genital chlamydial infection. BMJ (1996) 3.29
Infections with herpes simplex viruses (1). N Engl J Med (1986) 3.26
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet (2000) 3.22
Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med (1991) 3.19
Sexual lifestyles under scrutiny. Nature (1990) 3.19
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2000) 3.13
The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12
Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA (1998) 3.03
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis (1998) 2.98
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood (1999) 2.97
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 2.89
Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J Clin Invest (1998) 2.85
Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med (1995) 2.83
Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis (2001) 2.79
Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med (1987) 2.74
Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74
Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis (1998) 2.72
Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London. Lancet (1985) 2.72
A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med (1984) 2.71
Risk behaviours for HIV infection among injecting drug users attending a drug dependency clinic. BMJ (1989) 2.68
Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis (1985) 2.64
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis (2001) 2.63
A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med (1999) 2.62
Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis. J Infect Dis (1983) 2.60
In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med (1999) 2.58
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
Chronic fatigue. A prospective clinical and virologic study. JAMA (1990) 2.54
The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district. Br Med J (Clin Res Ed) (1986) 2.54
Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet (1994) 2.53
Anal and cervical intraepithelial neoplasia: possible parallel. Lancet (1989) 2.52
Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex virus types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA. J Clin Microbiol (1983) 2.50
Intravenous acyclovir treatment for primary genital herpes. Lancet (1982) 2.45
Active surveillance of sexual behaviour among homosexual men in London. Commun Dis Public Health (1998) 2.45
Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis (1989) 2.41
Evaluation of sexual health services within Australia and New Zealand. Med J Aust (1997) 2.39
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med (1992) 2.34
Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med (1983) 2.33
A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ (2001) 2.30
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Sexually transmitted diseases in children: adolescents. Genitourin Med (1993) 2.27
Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med (1992) 2.25
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24
Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med (1985) 2.23
Infections with herpes simplex viruses (2). N Engl J Med (1986) 2.22
Provision of sex education and early sexual experience: the relation examined. BMJ (1995) 2.21